Oncomatryx Biopharma
PrivateLast Round
Early Funding
Mar 30, 2026
Total Funding Raised
$67M
Company Overview
Oncomatryx Biopharma is a clinical-stage biotechnology company that develops precision drugs and diagnostics targeting the tumor microenvironment to treat invasive solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oncomatryx Biopharma Comps
Public and private peers based on sector, stage, and business model.
Oncomatryx Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 30, 2026 |
Oncomatryx Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Basque Government | Early Funding |
| Ekarpen | Early Funding |
| Center for Technological Development and Innovation | Early Funding |
| BBK Banku-fundazioa | Early Funding |
| Kutxa Fundazioa | Early Funding |
Oncomatryx Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oncomatryx Biopharma's valuation, stock price, and market status.
